Company Filing History:
Years Active: 2014-2020
Title: The Innovations of Inventor Makoto Ohyama
Introduction: Makoto Ohyama is a prominent inventor based in Yokohama, Japan, recognized for his significant contributions to the field of antifungal agents. With a remarkable portfolio of two patents, Ohyama has made strides in developing innovative solutions for combating fungal infections.
Latest Patents: Ohyama's most recent patents include a groundbreaking crystalline anti-trichophyton agent and its preparation process. This patent involves a stable crystal form of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-5-methylphenol, which boasts high purity for preservation, industrial manufacturing, and circulation, achieved through the use of a boron compound. In addition, he has developed a topical antifungal agent designed specifically for tinea, which features an active ingredient based on a compound with the skeleton of 2-(1H-pyrazol-1-yl)phenol, or its salts.
Career Highlights: Currently, Ohyama is affiliated with Meiji Seika Pharma Co., Ltd., a leading company in the pharmaceutical sector focusing on innovative healthcare solutions. His work within the organization underscores his commitment to advancing medical research and improving treatment options for patients affected by fungal infections.
Collaborations: Throughout his career, Makoto Ohyama has collaborated with notable coworkers such as Yuji Tabata and Maiko Iida. Their teamwork highlights the collaborative spirit prevalent in research institutions and companies dedicated to innovation in the pharmaceutical industry.
Conclusion: Makoto Ohyama stands out as an influential inventor whose patents are poised to make a significant impact in the field of antifungal treatments. His efforts through Meiji Seika Pharma Co., Ltd. demonstrate the vital role inventors play in the continuous pursuit of healthcare advancements.